Table 2 Means of outcome variables
| Â | Pre-action | Post-action | Change after the action | ||
|---|---|---|---|---|---|
| Â | mean | std. dev. | mean | std. dev. | Â |
Exposure group | |||||
Beta blocking agents | |||||
   Dayexp | 11.77 | 6.79 | 9.94 | 6.00 | -15.55% |
   Totalday | 98.14 | 46.32 | 162.31 | 55.46 | 65.39% |
   Totalexp | 1170.62 | 961.11 | 1632.12 | 1141.81 | 39.42% |
Calcium channel blockers, vascular effects | |||||
   Dayexp | 21.67 | 7.59 | 20.21 | 6.84 | -6.74% |
   Totalday | 101.55 | 45.30 | 161.79 | 55.38 | 59.32% |
   Totalexp | 2211.01 | 1293.61 | 3313.68 | 1641.13 | 49.87% |
ACE inhibitors, plain | |||||
   Dayexp | 23.16 | 10.06 | 21.75 | 9.25 | -6.09% |
   Totalday | 100.21 | 48.50 | 154.67 | 58.88 | 54.35% |
   Totalexp | 2341.01 | 1743.67 | 3374.22 | 2101.87 | 44.14% |
Comparison group | |||||
Beta blocking agents | |||||
   Dayexp | 13.07 | 10.74 | 13.04 | 10.10 | -0.23% |
   Totalday | 95.03 | 48.30 | 160.27 | 55.68 | 68.65% |
   Totalexp | 1287.80 | 1475.68 | 2117.25 | 1953.77 | 64.41% |
Calcium channel blockers, vascular effects | |||||
   Dayexp | 20.49 | 6.77 | 20.23 | 6.70 | -1.27% |
   Totalday | 90.44 | 47.96 | 159.23 | 54.86 | 76.06% |
   Totalexp | 1840.81 | 1171.14 | 3259.82 | 1641.34 | 77.09% |
ACE inhibitors, plain | |||||
   Dayexp | 23.65 | 9.05 | 24.28 | 10.23 | 2.66% |
   Totalday | 101.27 | 48.03 | 154.38 | 57.18 | 52.44% |
   Totalexp | 2383.21 | 1539.46 | 3669.49 | 1994.09 | 53.97% |